Related Experiment Video
Updated: Jul 6, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Long-term control of psoriasis is necessary]
J L Sánchez Carazo1, L Martínez Casimiro, V Alegre de Miguel
1Servicio de Dermatología, Consorcio Hospital General Universitario, Valencia, España. sanchez_joscar@gva.es
Actas Dermo-Sifiliograficas
|December 17, 2008
Summary
Psoriasis, a chronic inflammatory skin disease, significantly impacts quality of life. Newer biologic therapies like efalizumab offer effective, safer long-term treatment options compared to conventional drugs.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a prevalent immune-mediated inflammatory skin condition affecting 1.43% of the Spanish population.
- It causes significant physical and mental disability, severely impacting patients' quality of life.
- Conventional systemic treatments (methotrexate, cyclosporine, acitretin) carry risks of side effects and organ toxicity, limiting long-term use.
Purpose of the Study:
- To evaluate the efficacy and safety of biological agents for psoriasis treatment.
- To explore safer long-term therapeutic options for psoriasis patients, especially those with comorbidities.
- To assess the impact of improved psoriasis control on patient quality of life.
Main Methods:
- Review of accumulating clinical experience with biological agents, specifically efalizumab.
- Analysis of safety profiles and evidence of cumulative toxicity.
- Assessment of treatment effectiveness in managing psoriasis severity and comorbidities.
Main Results:
- Biological agents, such as efalizumab, demonstrate effectiveness in treating psoriasis.
- These newer therapies exhibit a favorable safety profile with no evidence of cumulative toxicity, allowing for long-term use.
- Improved psoriasis control correlates with enhanced patient quality of life.
Conclusions:
- Biological therapies represent a significant advancement in psoriasis management.
- Efalizumab and similar agents offer a safer and more sustainable long-term treatment strategy.
- Effective psoriasis management is crucial for improving overall patient well-being and quality of life.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications